Filing Details
- Accession Number:
- 0000899243-20-004181
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 21:26:32
- Reporting Period:
- 2020-02-11
- Accepted Time:
- 2020-02-11 21:26:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1681087 | Avrobio Inc. | AVRO | Biological Products, (No Disgnostic Substances) (2836) | 810710585 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742209 | Christopher Paige | C/O Avrobio, Inc. One Kendall Square, Bldg 300, Ste 201 Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-11 | 15,000 | $28.00 | 252,512 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
